Stem Cell Infusions Treat Severe Cases of SARS-COVID-19
Patients with compromised immune systems are experiencing what’s called a cytokine storm. This over-response by the immune system is causing pneumonia and lung fibrosis which is the cause of death.
Stem cell infusions with MSC’s (mesenchymal stem cells) have been used to treat patients with COPD, asthma, and IPF for years and FDA trials are underway. So it makes sense that these same stem cells would help patients recover from the complications of COVID-19.
Doctors in China have successfully treated elderly patients who were suffering with life threatening pneumonia. Within days the patients left the hospital.
Call 480-535-7868 for a free consultation or go to Contact and fill out your information.
The products and services discussed regarding COVID-19 are solely to enhance immune function or help manage systems and are not offered to prevent or cure the novel infection causes by SARS-CoV-2. Our clinical experience suggests that products or services offered may mitigate the consequences and alleviate some of the complications of the illness. The FDA has not approved these therapies expressly for use in COVID-19 or any viral disease and suggested use may be “off-label” or may lack approval for and are not intended to treat any disease indication but only offer symptomatic relief. While thereis evidence supporting such use, that evidence may not rise to the level necessary for acceptance by medical associations, health institutions, or regulatory bodies. There may be active professional disagreement and some professionals and regulatory bodies may be of the opinion that some recommendations are not helpful or appropriate.